Predictions
Addus Homecare Corp.
Start price
Target price
Perf. (%)
€79.50
29.04.23
29.04.23
€97.00
29.04.24
29.04.24
8.81%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€83.00
03.03.24
03.03.24
€180.00
31.05.26
31.05.26
-16.27%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€0.98
04.02.24
04.02.24
€1.50
31.10.25
31.10.25
14.29%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€2.30
29.10.23
29.10.23
€4.00
30.06.26
30.06.26
247.39%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.91
28.06.23
28.06.23
€7.00
31.01.26
31.01.26
-20.20%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.91
08.04.24
08.04.24
€3.00
08.04.25
08.04.25
-21.66%
27.04.24
27.04.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Bionxt Solutions Inc.
Start price
Target price
Perf. (%)
€0.49
26.04.23
26.04.23
€0.60
26.04.24
26.04.24
-46.61%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.49
23.04.24
23.04.24
€3.00
23.04.25
23.04.25
-8.41%
27.04.24
27.04.24
Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
Delticom AG
Start price
Target price
Perf. (%)
€2.06
15.04.24
15.04.24
-
15.04.25
15.04.25
22.33%
27.04.24
27.04.24
High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
Fair Value Reit-Ag
Start price
Target price
Perf. (%)
€3.66
15.04.24
15.04.24
-
15.04.25
15.04.25
2.73%
27.04.24
27.04.24
Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
Liquidia Technologies Inc
Start price
Target price
Perf. (%)
€13.78
13.04.24
13.04.24
€12.00
13.04.25
13.04.25
-18.00%
27.04.24
27.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-2.80%
27.04.24
27.04.24
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-0.66%
27.04.24
27.04.24
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.68
24.04.24
24.04.24
-
24.04.25
24.04.25
4.63%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Range Resources Corp.
Start price
Target price
Perf. (%)
€22.83
25.04.23
25.04.23
€29.04
25.04.24
25.04.24
53.31%
26.04.24
26.04.24
Establishment Labs Holdings Inc
Start price
Target price
Perf. (%)
€66.50
24.04.23
24.04.23
€80.71
24.04.24
24.04.24
-35.04%
25.04.24
25.04.24